Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paxton Bach

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 9, 2023
Amphetamine-Related Emergency Department Visits in Ontario, Canada, 2003-2020James A G Crispo, Lisa Liu, Paxton Bach, et al.
BMJ (Clinical Research Ed.)|January 10, 2024
Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort studyAmanda Slaunwhite, Jeong Eun Min, Heather Palis, et al.
Drug and Alcohol Dependence|November 18, 2023
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trialsHamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
JAMA Network Open|May 15, 2024
Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment ReceiptJeong Eun Min, Brenda Carolina Guerra-Alejos, Ruyu Yan, et al.
Drug and Alcohol Dependence Reports|May 1, 2026
U<b>se of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case serie</b>sAlexander Wong, Seonaid Nolan, Paxton Bach, et al.
BMJ Open|August 10, 2025
Comparative effectiveness of maintenance doses of opioid agonist treatment among individuals with opioid use disorder: a target trial emulation protocol using a population-based observational studyMichelle Zanette, Jeong Eun Min, Fahmida Homayra, et al.
BMJ Open|July 23, 2025
Comparative effectiveness of missed dose protocols of opioid agonist treatment in British Columbia, Canada: protocol for a population-based target trial emulationMomenul Haque Mondol, Jeong Eun Min, Megan Kurz, et al.
Drug and Alcohol Dependence|June 1, 2025
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020Elise Jackson, Paxton Bach, M Eugenia Socias, et al.
BMJ Open|September 1, 2025
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, CanadaRuyu Yan, Md Belal Hossain, Jeong Eun Min, et al.
Addiction (Abingdon, England)|June 2, 2026
Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010-2020Ruyu Yan, Jeong Eun Min, Megan Kurz, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 9, 2023
Amphetamine-Related Emergency Department Visits in Ontario, Canada, 2003-2020James A G Crispo, Lisa Liu, Paxton Bach, et al.
BMJ (Clinical Research Ed.)|January 10, 2024
Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort studyAmanda Slaunwhite, Jeong Eun Min, Heather Palis, et al.
Drug and Alcohol Dependence|November 18, 2023
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trialsHamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
JAMA Network Open|May 15, 2024
Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment ReceiptJeong Eun Min, Brenda Carolina Guerra-Alejos, Ruyu Yan, et al.
Drug and Alcohol Dependence Reports|May 1, 2026
U<b>se of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case serie</b>sAlexander Wong, Seonaid Nolan, Paxton Bach, et al.
BMJ Open|August 10, 2025
Comparative effectiveness of maintenance doses of opioid agonist treatment among individuals with opioid use disorder: a target trial emulation protocol using a population-based observational studyMichelle Zanette, Jeong Eun Min, Fahmida Homayra, et al.
BMJ Open|July 23, 2025
Comparative effectiveness of missed dose protocols of opioid agonist treatment in British Columbia, Canada: protocol for a population-based target trial emulationMomenul Haque Mondol, Jeong Eun Min, Megan Kurz, et al.
Drug and Alcohol Dependence|June 1, 2025
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020Elise Jackson, Paxton Bach, M Eugenia Socias, et al.
BMJ Open|September 1, 2025
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, CanadaRuyu Yan, Md Belal Hossain, Jeong Eun Min, et al.
Addiction (Abingdon, England)|June 2, 2026
Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010-2020Ruyu Yan, Jeong Eun Min, Megan Kurz, et al.
Pageof 9